CYBB and chronic granulomatous disease: As almost every second CGD patient suffers from intestinal inflammation (Marks et al., 2009; Falcone et al., 2016), further research is needed on the role of NOX2 in intestinal integrity, in particular in terms of local immune homeostasis and the microbiota.